MXPA06013633A - Inactivacion de un patogeno en una muestra a traves de un tratamiento con formalina y luz ultravioleta. - Google Patents

Inactivacion de un patogeno en una muestra a traves de un tratamiento con formalina y luz ultravioleta.

Info

Publication number
MXPA06013633A
MXPA06013633A MXPA06013633A MXPA06013633A MXPA06013633A MX PA06013633 A MXPA06013633 A MX PA06013633A MX PA06013633 A MXPA06013633 A MX PA06013633A MX PA06013633 A MXPA06013633 A MX PA06013633A MX PA06013633 A MXPA06013633 A MX PA06013633A
Authority
MX
Mexico
Prior art keywords
sample
virus
formalin
light
inactivation
Prior art date
Application number
MXPA06013633A
Other languages
English (en)
Spanish (es)
Inventor
Manfred Reiter
Wolfgang Mundt
Noel Barrett
Otfried Kistner
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of MXPA06013633A publication Critical patent/MXPA06013633A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M31/00—Means for providing, directing, scattering or concentrating light
    • C12M31/02—Means for providing, directing, scattering or concentrating light located outside the reactor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • A61L2103/05—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10—Apparatus features
    • A61L2202/11—Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA06013633A 2004-05-27 2005-05-26 Inactivacion de un patogeno en una muestra a traves de un tratamiento con formalina y luz ultravioleta. MXPA06013633A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57531004P 2004-05-27 2004-05-27
PCT/EP2005/005691 WO2005118000A1 (en) 2004-05-27 2005-05-26 Inactivation of a pathogen in a sample by a treatment with formalin and uv light

Publications (1)

Publication Number Publication Date
MXPA06013633A true MXPA06013633A (es) 2007-03-23

Family

ID=34968615

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06013633A MXPA06013633A (es) 2004-05-27 2005-05-26 Inactivacion de un patogeno en una muestra a traves de un tratamiento con formalina y luz ultravioleta.

Country Status (17)

Country Link
EP (1) EP1753470B1 (enExample)
JP (2) JP5502276B2 (enExample)
KR (1) KR101483337B1 (enExample)
CN (1) CN1956739B (enExample)
AU (1) AU2005249204B2 (enExample)
BR (1) BRPI0511467A (enExample)
CA (1) CA2567336C (enExample)
CR (1) CR8805A (enExample)
EA (1) EA010428B1 (enExample)
EC (1) ECSP067118A (enExample)
ES (1) ES2553457T3 (enExample)
IL (1) IL179262A (enExample)
MX (1) MXPA06013633A (enExample)
NO (1) NO20065912L (enExample)
NZ (1) NZ551857A (enExample)
WO (1) WO2005118000A1 (enExample)
ZA (1) ZA200610490B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06013633A (es) * 2004-05-27 2007-03-23 Baxter Int Inactivacion de un patogeno en una muestra a traves de un tratamiento con formalina y luz ultravioleta.
GB0706507D0 (en) * 2007-04-03 2007-05-09 Medi Immune Ltd Protective device
EP2173861B2 (en) 2007-06-15 2017-02-22 Amgen Inc. Methods of treating cell culture media for use in a bioreactor
JP6200805B2 (ja) * 2010-05-03 2017-09-20 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規な方法
JP5968795B2 (ja) * 2013-01-10 2016-08-10 四国化工機株式会社 紫外線殺菌装置
CN103992936B (zh) * 2014-04-22 2015-10-07 北京科兴生物制品有限公司 一种封闭式甲醛灭活病毒管道系统及其应用
WO2020023942A2 (en) 2018-07-27 2020-01-30 Terumo Bct Biotechnologies, Llc Fluid flow-through
CN111840596B (zh) * 2020-06-11 2022-03-11 南岳生物制药有限公司 核黄素光化学血浆灭活装置及其控制系统、控制方法
EP4190366A4 (en) 2020-07-27 2024-11-20 Riken INFECTION PREVENTION DEVICE AND INFECTION PREVENTION METHOD
US12447225B2 (en) 2021-06-25 2025-10-21 University Of South Florida Ultrafast-UV laser integrating cavity mediated inactivation of a pathogen
CN114229953B (zh) * 2021-12-25 2022-11-18 无锡诚源环境科技有限公司 腔体式紫外消毒器的紫外线剂量计算方法
GB2631765A (en) * 2023-07-13 2025-01-15 Univ Cranfield Viral inactivation reactor and method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB802048A (en) * 1955-08-26 1958-09-24 Parke Davis & Co Vaccine products and method for producing the same
US3926556A (en) * 1973-05-30 1975-12-16 Raymond Marcel Gut Boucher Biocidal electromagnetic synergistic process
SU1367487A1 (ru) * 1986-01-29 1995-10-27 Институт полиомиелита и вирусных энцефалитов АМН СССР Способ получения антирабической вакцины
US5247178A (en) * 1991-12-12 1993-09-21 Fusion Systems Corporation Method and apparatus for treating fluids by focusing reflected light on a thin fluid layer
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
DE10056096A1 (de) * 2000-11-13 2002-06-13 Bayer Ag Vorrichtung zur Bestrahlung von Flüssigkeiten
MXPA06013633A (es) * 2004-05-27 2007-03-23 Baxter Int Inactivacion de un patogeno en una muestra a traves de un tratamiento con formalina y luz ultravioleta.

Also Published As

Publication number Publication date
CA2567336A1 (en) 2005-12-15
CN1956739A (zh) 2007-05-02
EP1753470A1 (en) 2007-02-21
AU2005249204B2 (en) 2010-07-15
IL179262A0 (en) 2007-03-08
HK1105374A1 (zh) 2008-02-15
NO20065912L (no) 2007-02-26
ECSP067118A (enExample) 2007-02-28
EP1753470B1 (en) 2015-08-19
WO2005118000A1 (en) 2005-12-15
EA200602206A1 (ru) 2007-04-27
ES2553457T3 (es) 2015-12-09
JP5675690B2 (ja) 2015-02-25
IL179262A (en) 2011-01-31
CR8805A (es) 2007-06-19
JP2012143249A (ja) 2012-08-02
AU2005249204A1 (en) 2005-12-15
ZA200610490B (en) 2008-10-29
KR101483337B1 (ko) 2015-01-15
CA2567336C (en) 2010-11-23
KR20110099810A (ko) 2011-09-08
BRPI0511467A (pt) 2007-12-26
JP5502276B2 (ja) 2014-05-28
CN1956739B (zh) 2011-12-28
JP2008500303A (ja) 2008-01-10
NZ551857A (en) 2009-11-27
EA010428B1 (ru) 2008-08-29

Similar Documents

Publication Publication Date Title
JP5675690B2 (ja) ホルマリンおよびｕｖ光での処理によるサンプル中の病原体の不活化
Darnell et al. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
AU764592B2 (en) Methods and compositions for the selective modification of nucleic acids
AU694892B2 (en) Methods and compositions for the selective modification of nucleic acids
ES2270501T3 (es) Procedimiento para la inactivacion de virus envueltos.
JP3426237B2 (ja) 生物学的組成物の滅菌方法及びこの方法によって生成される製剤
US8703467B2 (en) Inactivation of a pathogen in a sample by a treatment with formalin and UV light
WO1998051660A9 (en) Methods and compositions for the selective modification of nucleic acids
CN105431171A (zh) 用于使用电子射线来病毒灭活的方法
US6165711A (en) Process for disintegrating nucleic acids and preparing biological products of guaranteed quality
US6352695B1 (en) Methods and compositions for the selective modification of nucleic acids
KR20070030852A (ko) 포르말린 및 ｕｖ광으로의 처리에 의한 샘플 중 병원균의불활성화
HK1105374B (en) A method for inactivating a virus contained in a sample
CA2716426A1 (en) Inactivation of a pathogen in a sample by a treatment with formalin and uv light
US20250177534A1 (en) Thermostable uv inactivated vaccines and other biopharmaceuticals
Zarubaev et al. Photodynamic inactivation of enveloped viruses by fullerene: study of efficacy and safety
Singh et al. Spectacular effects of ultraviolet C radiation, gamma radiation, X-ray radiation & heat treatment on disinfection rate of SARS-COVID virus-2
Gawish et al. In vitro effects of different concentrations of aqueous ozone on cells infected with herpes virus
Sofer Part 4, culture media, biotechnology products, and vaccines
Mayerhofer et al. UV irradiation for the manufacturing of viral vaccines: state-of-the-art and perspectives in modern vaccine processing
Mirshafiee et al. Induction of nucleic acid damage in viral genomes using riboflavin in combination with UV Light

Legal Events

Date Code Title Description
FG Grant or registration